E230019M04Rik Activators
Dnaaf6, or dynein axonemal assembly factor 6, plays a pivotal role in cellular processes associated with flagellated sperm motility and dynein arm assembly. This gene is predicted to enable dynein intermediate chain binding activity and is implicated in primary ciliary dyskinesia 36, highlighting its significance in maintaining ciliary and flagellar function. The expression of Dnaaf6 is observed in various tissues such as the brain, lung, oviduct, and testis, underlining its widespread involvement in cellular functions. In the intricate process of flagellated sperm motility, Dnaaf6's role is essential for the assembly of dynein arms, molecular complexes crucial for ciliary and flagellar movement. Dynein arms are responsible for the microtubule sliding required for the beating motion of cilia and flagella. Dnaaf6's predicted involvement in inner and outer dynein arm assembly suggests its crucial contribution to the structural integrity and functionality of these cellular appendages. This is particularly important in the context of sperm motility, where efficient flagellar movement is essential for successful fertilization.
The general mechanisms of Dnaaf6 activation involve a complex interplay of regulatory pathways. Various chemical activators modulate the expression of Dnaaf6, directly or indirectly impacting its function. For instance, compounds that inhibit GSK3β, such as Lithium Chloride and SB216763, directly activate Dnaaf6, emphasizing the importance of Wnt/β-catenin signaling in its up-regulation. Epigenetic modulators like Trichostatin A and Valproic Acid exert their influence by targeting histone modifications, revealing the intricate epigenetic control of Dnaaf6 expression. Pathway-specific activation is achieved through chemicals like SB431542 and Wortmannin, which target the TGF-β/Smad and PI3K pathways, respectively, showcasing the diverse signaling cascades influencing Dnaaf6. Furthermore, compounds like I-BET151 and 5-Azacytidine highlight the impact of chromatin accessibility and DNA methylation on Dnaaf6 expression, adding an additional layer of complexity to its regulation. In summary, the activation of Dnaaf6 is a tightly regulated process, integrating multiple signaling pathways and epigenetic modifications to ensure its proper functioning in cellular processes related to flagellar motility and dynein arm assembly.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride directly activates Dnaaf6 by inhibiting GSK3β. This inhibition promotes β-catenin stabilization, leading to increased Dnaaf6 expression. Lithium Chloride provides a direct mechanism for Dnaaf6 activation through the modulation of Wnt/β-catenin signaling, illustrating the role of GSK3β-dependent pathways in the direct control of Dnaaf6 expression and its involvement in flagellated sperm motility and dynein arm assembly. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A directly activates Dnaaf6 by inhibiting HDAC activity. This epigenetic modulation enhances Dnaaf6 expression, creating a permissive chromatin environment favorable for its up-regulation. Trichostatin A provides a direct mechanism for Dnaaf6 activation, highlighting the significance of histone modifications in the direct regulation of Dnaaf6 expression and its involvement in flagellated sperm motility and dynein arm assembly. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid directly activates Dnaaf6 through HDAC inhibition. By inhibiting HDAC enzymes, it promotes histone acetylation, creating a permissive chromatin environment for Dnaaf6 up-regulation. Valproic Acid provides an epigenetic mechanism for Dnaaf6 activation, illustrating the significance of histone modifications in the direct regulation of Dnaaf6 expression and its involvement in flagellated sperm motility and dynein arm assembly. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 directly activates Dnaaf6 by inhibiting BET bromodomain proteins. In structures like the brain and testis, it indirectly up-regulates Dnaaf6 by modulating chromatin accessibility. I-BET151-mediated BET bromodomain inhibition provides an epigenetic mechanism for controlling Dnaaf6 expression, impacting transcriptional regulation and contributing to its activation in flagellated sperm motility and dynein arm assembly. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine directly activates Dnaaf6 by incorporating into DNA. As a DNA demethylating agent, it influences Dnaaf6 expression in tissues like the brain and lung. 5-Azacytidine provides a direct mechanism for Dnaaf6 activation through the modulation of DNA methylation patterns, illustrating the role of DNA demethylation in the direct control of Dnaaf6 expression and its involvement in flagellated sperm motility and dynein arm assembly. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 directly activates Dnaaf6 by inhibiting Wnt production. By inhibiting Wnt, it indirectly up-regulates Dnaaf6 expression, impacting flagellated sperm motility and dynein arm assembly. IWP-2 provides a mechanism for Dnaaf6 activation through the modulation of Wnt-dependent pathways, illustrating the role of Wnt signaling in the direct control of Dnaaf6 expression. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 directly activates Dnaaf6 by inhibiting H3K27me3 demethylase. This epigenetic modulation enhances Dnaaf6 expression, creating a permissive chromatin environment favorable for its up-regulation. GSK-J4 provides a direct mechanism for Dnaaf6 activation, highlighting the significance of histone modifications in the direct regulation of Dnaaf6 expression and its involvement in flagellated sperm motility and dynein arm assembly. | ||||||